Area of research
Genetics · Immunology
Research interest
Research interests include Glioma Diagnosis and Treatment, interferon and immune responses, Brain Metastases and Treatment, and MicroRNA in disease regulation.
Impact of predictive impact of MGMT promoter methylation in malignant astrocytomas depends on the methylation subgroup.
Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?
Clinical and molecular features associated with long-term survival of elderly patients with glioblastoma.
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma
MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM
ACTR-18. MOLECULAR GENETIC, HOST-DERIVED AND CLINICAL DETERMINANTS OF LONG-TERM SURVIVAL IN GLIOBLASTOMA: AN UPDATE FROM THE BRAIN TUMOR FUNDERS’ COLLABORATIVE CONSORTIUM
Reply to F. Felix et al and M.F. Fay et al
Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells
ATNT-10DOES VALPROIC ACID IMPROVE SURVIVAL IN GLIOBLASTOMA? A META-ANALYSIS OF RANDOMIZED TRIALS IN NEWLY DIAGNOSED GLIOBLASTOMA
Interferon-β Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells
Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective